Megaloblastic anaemia with normal mean cell volume

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

Leukemia·2026

CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3.

Leukemia & lymphoma·2016

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

Leukemia·2016

Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease.

Leukemia·2016

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.

Leukemia·2012

13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia.

Leukemia·2010

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Fluoroquinolone-resistant Salmonella Typhi presenting as ileal perforation in a traveler.

Journal of surgical case reports·2026

Teclistamab in relapsed/refractory Waldenstro m macroglobulinemia.

Haematologica·2026

Human granulocytic anaplasmosis-associated myopericarditis: a case report and literature review of a treatable cause of myopericarditis.

Journal of medical case reports·2026

Pagetoid reticulosis (Woringer-Kolopp disease) mimicking eczema: a case report with immunophenotypic analysis and literature review.

Frontiers in immunology·2026

[Pleural Well-differentiated Papillary Mesothelial Tumor Presenting with Recurrent Pneumothorax and Pleural Effusion: A Case Report].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2026

Anthracofibrosis: an under-recognised mimic of malignancy and tuberculosis in a migrant population.

Internal medicine journal·2026

Related Experiment Videos

Megaloblastic anaemia with normal mean cell volume

Related Concept Videos

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3.

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease.

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.

13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Fluoroquinolone-resistant Salmonella Typhi presenting as ileal perforation in a traveler.

Teclistamab in relapsed/refractory Waldenstro m macroglobulinemia.

Human granulocytic anaplasmosis-associated myopericarditis: a case report and literature review of a treatable cause of myopericarditis.

Pagetoid reticulosis (Woringer-Kolopp disease) mimicking eczema: a case report with immunophenotypic analysis and literature review.

[Pleural Well-differentiated Papillary Mesothelial Tumor Presenting with Recurrent Pneumothorax and Pleural Effusion: A Case Report].

Anthracofibrosis: an under-recognised mimic of malignancy and tuberculosis in a migrant population.

Related Experiment Videos

Megaloblastic anaemia with normal mean cell volume

Related Concept Videos

Related Articles